🇺🇸 FDA

Intelligence · Clinical Pipeline

United Therapeutics Europe Pipeline

All ClinicalTrials.gov programs at United Therapeutics Europe — phase, modality, and trial IDs.

Programs
336

Quick answer

United Therapeutics Europe has 336 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. 0.5% Ivermectin lotion

    United Therapeutics Europe Ltd

    Pediculosis Capitis

    phase 2 small molecule completed

    1 trial

  2. 1. Intranasal oxytocin spray

    United Therapeutics Europe Ltd

    Autism Spectrum Disorder

    phase 2 small molecule active

    1 trial

  3. 10 GE Xenokidney

    United Therapeutics Europe Ltd

    ESRD (End-Stage Renal Disease)

    phase 2 mab active

    1 trial

  4. 177Lu-J591

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 2 small molecule active

    1 trial

  5. 177Lu-PSMA-617

    United Therapeutics Europe Ltd

    Metastatic Hormone Naive Prostate Cancer

    phase 2 small molecule active

    1 trial

  6. 2-deoxyglucose

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 2 small molecule terminated

    1 trial

  7. 225Ac-J591

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 2 small molecule active

    2 trials

  8. 2mg Buprenex and 380mg Vivitrol

    United Therapeutics Europe Ltd

    Post Traumatic Stress Disorder

    phase 2 small molecule terminated

    1 trial

  9. 3,4-Methylenedioxymethamphetamine (MDMA)

    United Therapeutics Europe Ltd

    Post Traumatic Stress Disorder

    phase 2 small molecule active

    1 trial

  10. 60 mg Prednisone

    United Therapeutics Europe Ltd

    Airway Inflammation

    phase 2 small molecule completed

    1 trial

  11. 70 mL red beetroot juice

    United Therapeutics Europe Ltd

    Overweight

    phase 2 other active

    1 trial

  12. ADENOVIRUS/PSA VACCINE

    United Therapeutics Europe Ltd

    Hormone Refractory Prostate Cancer

    phase 2 mab completed

    1 trial

  13. APD811

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    phase 2 small molecule completed

    1 trial

  14. AZD2014

    United Therapeutics Europe Ltd

    Neurofibromatosis 2

    phase 2 small molecule completed

    1 trial

  15. AZD5069

    United Therapeutics Europe Ltd

    Metastatic Castration Resistant Prostate Cancer

    phase 2 small molecule terminated

    1 trial

  16. AZD5363

    United Therapeutics Europe Ltd

    Adenocarcinoma of the Prostate

    phase 2 small molecule active

    1 trial

  17. AZD6738

    United Therapeutics Europe Ltd

    Breast Neoplasm

    phase 2 small molecule active

    1 trial

  18. AZD8931

    United Therapeutics Europe Ltd

    Metastatic Colorectal Cancer

    phase 2 small molecule completed

    1 trial

  19. Abiraterone Acetate

    United Therapeutics Europe Ltd

    Metastatic Castration Resistant Prostate Cancer

    phase 2 small molecule terminated

    1 trial

  20. Abiraterone acetate

    United Therapeutics Europe Ltd

    Prostate Cancer (Adenocarcinoma)

    phase 2 small molecule active

    1 trial

  21. Acalabrutinib

    United Therapeutics Europe Ltd

    Mantle Cell Lymphoma

    phase 2 small molecule active

    1 trial

  22. Active cTBS

    United Therapeutics Europe Ltd

    Post-Concussion Syndrome

    phase 2 other active

    1 trial

  23. Active tDCS + task oriented practice

    United Therapeutics Europe Ltd

    Cervical Spinal Cord Injruy

    phase 2 other completed

    1 trial

  24. Acupuncture

    United Therapeutics Europe Ltd

    Persian Gulf Syndrome

    phase 2 other completed

    1 trial

  25. Adaptive-Planning Organ Localisation (A-POLO) (Planning CT scan)

    United Therapeutics Europe Ltd

    Bladder Cancer

    phase 2 other active

    1 trial

  26. Advair HFA

    United Therapeutics Europe Ltd

    Altitude Edema

    phase 2 small molecule active

    1 trial

  27. Aerobic exercise training

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 2 other completed

    1 trial

  28. Afatinib and Paclitaxel

    United Therapeutics Europe Ltd

    Esophageal Cancer

    phase 2 small molecule completed

    1 trial

  29. Aldesleukin

    United Therapeutics Europe Ltd

    Type 1 Diabetes

    phase 2 small molecule completed

    1 trial

  30. Allopregnanolone injection

    United Therapeutics Europe Ltd

    Traumatic Brain Injury

    phase 2 small molecule completed

    1 trial

  31. Alpelisib

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 small molecule completed

    1 trial

  32. Alteplase

    United Therapeutics Europe Ltd

    Myocardial Infarction

    phase 2 small molecule completed

    1 trial

  33. Amiloride

    United Therapeutics Europe Ltd

    Secondary Progressive Multiple Sclerosis

    phase 2 small molecule completed

    1 trial

  34. Angiotensin (1-7)

    United Therapeutics Europe Ltd

    Traumatic Brain Injury

    phase 2 small molecule active

    1 trial

  35. Anti-CD40 Agonist Monoclonal Antibody CDX-1140

    United Therapeutics Europe Ltd

    Ovarian Clear Cell Adenocarcinoma

    phase 2 mab active

    1 trial

  36. Antibody UB-421

    United Therapeutics Europe Ltd

    HIV-1 Infection in Adults

    phase 2 small molecule completed

    1 trial

  37. Antipyrine-benzocaine otic solution

    United Therapeutics Europe Ltd

    Asthma

    phase 2 small molecule active

    1 trial

  38. Aspirin

    United Therapeutics Europe Ltd

    Vestibular Schwannoma

    phase 2 small molecule active

    1 trial

  39. Aspirin 75mg

    United Therapeutics Europe Ltd

    Acute Lung Injury

    phase 2 small molecule completed

    1 trial

  40. Atezolizumab

    United Therapeutics Europe Ltd

    Metastatic Colorectal Carcinoma

    phase 2 small molecule completed

    1 trial

  41. Atezolizumab

    United Therapeutics Europe Ltd

    Locally Advanced Hepatocellular Carcinoma

    phase 2 mab active

    1 trial

  42. Atorvastatin Calcium

    United Therapeutics Europe Ltd

    Traumatic Brain Injury

    phase 2 small molecule active

    1 trial

  43. Autologous Fat Transfer

    United Therapeutics Europe Ltd

    Wound

    phase 2 other completed

    1 trial

  44. Autologous Room Temperature stored Platelet transfusion

    United Therapeutics Europe Ltd

    Reversal of Platelet Aggregation Inhibitors

    phase 2 mab active

    1 trial

  45. Autologous Skin Fibroblasts

    United Therapeutics Europe Ltd

    Amputation

    phase 2 mab active

    1 trial

  46. Autologous Volar Fibroblast Injection into the Terminal Limb of Amputees

    United Therapeutics Europe Ltd

    Amputation

    phase 2 other active

    1 trial

  47. Avastin® (bevacizumab)

    United Therapeutics Europe Ltd

    Corneal Neovascularization

    phase 2 small molecule completed

    1 trial

  48. Avutometinib

    United Therapeutics Europe Ltd

    Glioblastoma Multiforme (GBM)

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many pipeline programs does United Therapeutics Europe have?

336 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.